Baishi Meishi Guibao's US stock rose more than 5% before trading
胡胡胡美丽_ss
发表于 2024-9-27 17:01:51
203
0
0
According to the AI news, the US stock market of Bristol Myers Squibb rose more than 5% before trading. The US regulatory authorities approved its Cobenfy for the treatment of schizophrenia, which is the first drug approved for the treatment of schizophrenia in decades.
CandyLake.com 系信息发布平台,仅提供信息存储空间服务。
声明:该文观点仅代表作者本人,本文不代表CandyLake.com立场,且不构成建议,请谨慎对待。
声明:该文观点仅代表作者本人,本文不代表CandyLake.com立场,且不构成建议,请谨慎对待。
猜你喜欢
- JD's US stock market fell nearly 7% before trading
- The US stock market suffered a "black door" in September, with Nvidia evaporating nearly 2 trillion yuan overnight, creating the largest daily market value loss in US stock history
- Baishi Meishi Guibao's US stock rose more than 5% before trading
- Jiaxin Wealth Management's US stock market rose nearly 8% before trading
- Top 20 US stock transactions: ASML's performance hits rock bottom, leading to collapse of US chip stocks
- The US stock market is about to undergo significant changes. The New York Stock Exchange has announced an extension of trading hours!
- ULTRA beauty stocks rose over 11% before trading
- Investment Strategy for US Stocks in 2025: Re inflation Risk Restarting, US Stocks Rise and Fall